— Know what they know.
Not Investment Advice

ZY NASDAQ

Zymergen Inc.
1W: -8.7% 1M: -10.7% 3M: +13.0% 1Y: -80.7%
$2.43
Last traded 2022-10-18 — delisted
NASDAQ · Basic Materials · Chemicals - Specialty

Balance Sheet Trends

Total Assets
$522M +71.3% ▲
Total Liabilities
$114M -89.1% ▼
Shareholders Equity
$408M +154.9% ▲
Cash & Investments
$386M +82.9% ▲
Total Debt
$44M -44.6% ▼
Net Debt
-$342M -161.4% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2019FY2020FY2021
— Assets —
Cash$144M$210M$386M
Short-Term Investments$1M$931K$0
Cash & ST Investments$145M$211M$386M
Net Receivables$3M$5M$3M
Inventory$2M$5M$6M
Other Current Assets$16M$8M$12M
Total Current Assets$166M$229M$407M
Property, Plant & Equip.$45M$49M$54M
Goodwill & Intangibles$7M$16M$49M
Long-Term Investments$0$0$0
Other Non-Current Assets$10M$11M$12M
Total Non-Current Assets$62M$76M$115M
Total Assets$228M$305M$522M
— Liabilities —
Accounts Payable$14M$12M$5M
Short-Term Debt$78M$79M$44M
Deferred Revenue$2M$3M$4M
Other Current Liabilities$17M$27M$20M
Total Current Liabilities$112M$121M$74M
Long-Term Debt$0$0$0
Other Non-Current Liab.$616M$927M$40M
Total Non-Current Liabilities$616M$927M$40M
Total Liabilities$727M$1.0B$114M
— Equity —
Common Stock$11K$13K$103K
Retained Earnings-$512M-$774M-$1.1B
Accumulated OCI-$31M-$48M-$522M
Total Stockholders Equity-$500M-$744M$408M
Total Liabilities & Equity$228M$305M$522M
— Key Metrics —
Total Debt$78M$79M$44M
Net Debt-$65M-$131M-$342M
Total Investments$1M$931K$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms